Literature DB >> 6337709

Failure of 2-deoxy-D-glucose and 5-thio-D-glucose to kill hypoxic cells of two murine tumors.

I F Tannock, P Guttman, A M Rauth.   

Abstract

We have administered the glycolysis inhibitors 2-deoxy-D-glucose and 5-thio-D-glucose to C3H/HeJ mice bearing KHT or 16/C transplantable tumors to seek evidence for hypoxic cell toxicity in vivo. The drugs were given (a) with or without insulin, (b) as large single doses or as multiple hourly injections, and (c) alone or immediately after the tumors had received radiation to kill most of the aerobic cell population. Tumor response was assessed by growth delay or by lung colony assay. Limiting toxicity of 2-deoxy-D-glucose and 5-thio-D-glucose was neurological, leading to seizures and/or death, and this toxicity was increased by insulin. The drugs had at most minimal effects on the growth of either untreated or irradiated tumors at maximal tolerated doses. Despite the known selective toxicity of these glucose analogues for hypoxic cells in tissue culture, we have found them to be ineffective in killing hypoxic cells of two murine tumors.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6337709

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  3 in total

1.  Apparent glucose utilization in Walker 256 metastatic brain tumors.

Authors:  R G Blasberg; M Shinohara; W R Shapiro; C S Patlak; K D Pettigrew; J D Fenstermacher
Journal:  J Neurooncol       Date:  1986       Impact factor: 4.130

2.  Apparent glucose utilization in Walker 256 metastatic brain tumors.

Authors:  R G Blasberg; M Shinohara; W R Shapiro; C S Patlak; K D Pettigrew; J D Fenstermacher
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

3.  Response of an ocular melanoma to subconjunctival injection of 5-thio-D-glucose or cis-platin.

Authors:  K A Skov; C Kumi; J Rootman; N Bussanich; M O Fellenz
Journal:  Br J Cancer       Date:  1987-05       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.